Correlation between intestinal BMP2, IFNγ, and neural death in experimental infection with Trypanosoma cruzi

About the Authors:

José Rodrigues do Carmo Neto

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing

Affiliation: Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil

ORCID logo https://orcid.org/0000-0002-5748-5112

Marcos Vinicius da Silva

Roles Methodology, Project administration, Resources, Supervision, Writing – review & editing

Affiliation: Department of Microbiology, Immunology and Parasitology, Institute of Biological and Natural Sciences of Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil

Yarlla Loyane Lira Braga

Roles Investigation, Methodology

Affiliation: Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil

Arthur Wilson Florencio da Costa

Roles Investigation, Methodology

Affiliation: Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil

Simone Gonçalves Fonseca

Roles Conceptualization, Writing – review & editing

Affiliation: Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil

Patricia Resende Alô Nagib

Roles Writing – review & editing

Affiliation: Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil

Mara Rúbia Nunes Celes

Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review & editing

Affiliation: Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil

ORCID logo https://orcid.org/0000-0002-4733-007X

Milton Adriano Pelli Oliveira

Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review & editing

Affiliation: Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil

Juliana Reis Machado

Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – review & editing

* E-mail: [email protected]

Affiliations Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiania, GO, Brazil, Department of General Pathology, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil

Introduction

Bone morphogenetic proteins (BMPs), included in the transforming growth factor beta (TGF-β) superfamily, are involve from embryogenesis to adult organ cell homeostasis [1–5]. Initially described in bone formation [6], this protein group is divided into at least four subgroups with similar functions and biochemical structures [2]. One of the first reports of BMP2 was studied for its osteoinductive capacity. In addition, this protein is directly involved in intestinal homeostasis [7], intestine organogenesis, epithelial cell renovation, and myenteric plexus (MP) neuronal homeostasis [1, 7–9]. There is a network in the MP from which a muscular macrophage subpopulation (MMS) releases basal levels of BMP2 to neurons of this structure [7]. In response, these neurons produce the maintenance factor for the macrophage colony to regulate this MMS [7, 9]. This communication results in homeostasis of the gastrointestinal tract, and, when the MMS is depleted, BMP2 is not produced, leading to abnormal motility of the intestine [7].

BMP2 expression may be altered in diseases characterized by enteric nervous system (ENS) disturbances and altered intestinal motility. In Hirschsprung’s disease, BMP2 expression is upregulated compared to that in the normal gut [10]. In rats with induced diabetes, BMP2 expression is downregulated and returns to normal levels after insulin administration [11]. Despite differences in pathophysiology, both diseases are related to inflammation, neuronal loss, and intestinal dysmotility [7, 10–12]. It is reasonable that in infectious diseases that have neuronal damage, alterations in BMP2 levels could be associated with the progression of enteric nervous system pathophysiology, but there are no reports investigating this issue.

Three to ten percent of patients with chronic Chagas disease (CD) develop the digestive form, in which disturbances in the ENS lead to megacolon [13]. Currently, it is accepted that the progression of this form is related to neuronal loss due to infection, mainly due to the inflammatory process caused by Trypanosoma cruzi [14]. Observed differences in the inflammatory intestinal microenvironment between infected individuals without megacolon and those with megacolon suggest that inflammation effects the progression of the intestinal form. In the megacolon, the increases in eosinophils, mast cells, and macrophages are directly correlated with fibrosis in the organ, indicating they are participants in tissue damage [15]. Other cells, such as natural killer cells and cytotoxic T lymphocytes, have also been suggested as mediators of damage to ENS components [16]. In an experimental model, these same relationships have already been reported [17–19], including those regarding the participation of pro-inflammatory cytokines in the acute phase [20]. Thus, the inflammatory response generated by the host against T. cruzi needs to be extremely controlled, since in infected individuals without megacolon, there is less intestinal involvement and fewer tissue inflammatory cells [15, 16].

However, the molecular mechanisms underlying megacolon progression have not been elucidated. The intestinal myenteric plexus is the structure that is most affected by T. cruzi infection [21–23], with a broadly documented reduction of neuron cells [16, 23–26]. Since one of the most important functions of this structure is intestinal peristalsis regulation [27], neuronal damage leads to loss of intestinal homeostasis. It is known that neuropeptides, growth factors, and cytokines are directly involved in intestinal homeostasis, but so far little has been investigated in chagasic megacolon [28]. Since BMP2 can modulate and be modulated by the immune system and control intestinal homeostasis, the aim of this study was to correlate the production of intestinal BMP2 with cytokines and histopathological changes in mice infected with T. cruzi in different phases of experimental infection.

Material and methods

Animals

In the present study, male C57Bl/6 mice, aged 6 to 8 weeks, were used. Mice were either infected with the Y strain of T. cruzi or not infected, as a control. The animals were supplied by and maintained at the Bioterium of the Institute of Tropical Pathology and Public Health of the Federal University of Goias under controlled and known conditions: in plastic cages of 414 mm × 168 mm, temperature between 20 and 25°C, humidity between 45 and 55%, and with constant renewal of air and with a 12h photoperiod. They were fed with feed of known composition (Nuvilab-CR1, NUVITAL, Brazil) and were offered water ad libitum. All components of the cage, such as water, wood shavings, and feed, were autoclaved before use and exposure to the animals. The project was submitted to the Animal Use Ethics Committee of the Federal University of Goias and was approved under identification 051/19. The animals were monitored weekly until the date of euthanasia to minimize suffering as much as possible.

Parasites and experimental infection

Blood trypomastigotes, maintained through serial passage in Balb/C mice, were inoculated in the mice destined for the experiment. Male C57Bl/6 mice were infected with 1000 trypomastigote forms of the Y strain of T. cruzi. After infection, mice were maintained for 30 days (acute phase) (n = 6) or 90 days (chronic phase) (n = 10). The chronic phase was characterized by blood parasitemia equal to zero and intestinal fibrosis. Non-infected control groups were maintained for the same amounts of time and under the same experimental conditions (30 days for acute phase with n = 5 and 90 days for chronic phase with n = 7). After acute or chronic phase development, mice were euthanized through cervical dislocation after confirmation of anesthetic status, induced by intraperitoneal administration of anesthetic solution at 5% xylazine hydrochloride and 10% ketamine. For all mice, two fragments of the colon were collected: the distal fragment for histological analysis and the proximal fragment for cytokine dosage. Throughout the study, there was no mortality. The experiment was repeated twice.

Determination of parasitemia

The parasitemia of infected mice was carried out until no more circulating blood trypomastigotes were found. Through the caudal vein, 5 μL of blood was taken from the mice to assess the level of parasitemia. Under a slide and coverslip, parasites were counted in 50 random fields under an optical microscope at 400× magnification [29]. This observation was made every 3 days after the inoculum. The parasitemia result was normalized by the area of the slide and the area observed under the microscope according to the magnification used [30].

Histopathological evaluations

The distal segment of the colon (comparable to the proximal two-thirds of the transverse colon in humans) of all groups was collected (approximately 1 cm), washed in cold saline solution, and fixed in 4% paraformaldehyde for 48 hours. Then, the material was dehydrated in an increasing series of ethyl alcohols, transferred to xylol, and then embedded in paraffin. The fragment was positioned on the longitudinal axis perpendicular to the microtomy plane. Serial 5 μm-thick sections were cut (e. g., every fifth section, with a gap of 25 μm between cuts) and selected sections were stained using H&E, Giemsa, and picrosirius red for intestinal analysis.

Inflammatory infiltrate quantification.

Hematoxylin-eosin (HE)-stained slides were used to analyze the inflammatory infiltrate. From a light microscope attached to the camera, 10 micrographs (30 micrographs per animal) of each of the three serial fragments (100 μm apart) were captured under 400× magnification for further analysis. The intensity of the inflammatory process was assessed in the submucosal and muscular layers and classified as 0 (normal), 1 (discrete), 2 (moderate), and 3 (accentuated). After categorizing the photos, the mean of each case obtained was classified according to the following score: 0–0.3 = normal; 0.4–1.0 = discrete; 1.1–2 = moderate; 2.1–3 = accentuated (adapted from [31]).

Myenteric plexus neuron quantification.

Giemsa-stained slides were used to quantify neurons. Four serial sections with 100 μm between each were evaluated under light microscopy at 400× magnification. This distance was selected so that a larger area could be analyzed. Neurons were counted in 30 random fields at 400× magnification in each cut (120 fields per animal). The result was expressed as the number of neurons/field.

Fibrous connective tissue quantification.

Sirius-Red stained slides were used for morphometric evaluation of the deposition of connective tissue in the mucosa, submucosa, and intestinal muscle layers, except for the serous layer. Collagen analyses were carried out under polarized light and quantified using the Axion Vision software (ZEISS). For each intestinal fragment, 20 fields were analyzed at 400× magnification. The results were expressed as collagen (%) per unit area [32].

Intestinal homogenates and cytokine measurements

The colon proximal fragment (approximately 1 cm) was transferred to an Eppendorf tube containing 1× Phosphate Buffered Saline solution and Complete ™ protease inhibitor (SIGMA, USA). Then, the fragments were subjected to homogenization in a homogenizer (DREMEL, EUA). The homogenates obtained were centrifuged at 12000 × g for 30 min, and the respective supernatants were stored at -80°C for quantification of BMP2, cytokines, and total proteins. The levels of BMP2, IFNγ, TNF-α, and IL-10 in the proximal intestine homogenates were measured by an enzyme-linked immunosorbent assay (ELISA). For BMP2, the commercial kit PEPROTECH (Lot # 0614T255) was used. For IFNγ (Lot # P209723) and TNF-α (Lot # P210424), the kit used was from the R&D System. Meanwhile, for IL-10, we used the BD OptEIA™ kit (Lot # 9164829). The methodologies were carried out according to the manufacturers’ instructions. For the colorimetric reaction, 3, 3, 5, 5-tetramethylbenzidine (TMB) (BD Pharmingen, USA) was used as a peroxidase substrate and the reading was made on a 450 nm filter in a microplate reader (Bio-Rad 2550 READER EIA, USA). The concentration of total proteins in the intestinal homogenate was determined using a NanoDrop spectrophotometer (Thermo Fisher Scientific, USA) and was used to normalize the concentrations of BMP2 and cytokines. The final concentration was given in pg/mg of tissue.

Statistical analysis

Statistical analyses were performed using GraphPad Prism 6.0 (GraphPad Software—USA). The verification of the normal distribution of the quantitative variables was assessed by the Shapiro-Wilk test. For comparisons between two groups, an unpaired t-test was used for data with a normal distribution, and the Mann-Whitney test was used for data with a non-normal distribution. Correlations were made using the Spearman test with a 95% confidence interval. The results were considered statistically significant at p <0.05.

Results

Parasitemia

In order to monitor the infection by the T. cruzi Y strain in C57Bl/6 mice, parasitemia measurements were performed every three days after the inoculum. The analysis was carried out until the circulating blood trypomastigote forms were no longer found. Here, we observed a sustainable parasitemia in the acute phase, with detectable blood trypomastigote forms from the 5th to 32nd days (Fig 1A). Peak parasitemia was observed at 8 days of infection (Fig 1A). At the 29th day after infection, 93% of the animals showed reduced parasitemia. As expected, infected mice were able to control the blood parasite circulation at the end of the acute phase.

[Figure omitted. See PDF.]

Fig 1. Blood parasitemia and intestinal histopathological differences between the acute and chronic phases of T. cruzi infected C57Bl/6 mice.

C57Bl/6 mice were subcutaneously infected with 1000 blood trypomastigote forms of T. cruzi Y strain. (A) Parasitemia was determined by counting the number of trypomastigotes in 5 μl of blood collected from the caudal vein. (B) Intensity score of the intestinal inflammatory infiltrate. Intestinal photomicrographs of mice at the (B1) acute phase and (B2) chronic phase. (C) Number of neurons in the myenteric plexus. Intestinal photomicrographs of uninfected mice at 30 days (C1) and infected mice at the acute phase (C2). Neurons of the myenteric plexus are highlighted within black lines and highlighted by the black arrow. The white arrow represents an inflammatory infiltrate located close to the neurons of infected group mice during the acute phase. (D) Percentage of collagen deposited in the intestine. Intestinal photomicrographs of uninfected mice at (D1) 30 and (D2) 90 days and of infected mice during the (D3) acute and (D4) chronic phases. Mann-Whitney test. * Significant statistical differences at p < 0.05.

https://doi.org/10.1371/journal.pone.0246692.g001

Intestinal inflammation scores, neuronal quantification, and fibrosis deposition

To assess the extent of intestinal commitment in infected mice, the inflammatory infiltrate, neuronal loss, and collagen deposition were evaluated. The intestinal inflammatory infiltrate in the acute phase was more intense than that in the chronic phase (p = 0.0043) (Fig 1B). Most animals (approximately 80%) in the acute phase of infection showed a moderate inflammatory process (score: 1.1–1.5), whereas in the chronic phase, the inflammatory process decreased, showing a mild infiltrate for all animals (score: 0.3–0.6) (Fig 1B). The number of neurons was quantitated in the myenteric plexus to evaluate intestinal neural damage. A significant decrease in the number of neurons was detected in the acute phase of infection (30 days) (p = 0.0043), which was maintained during the chronic phase (90 days) (Fig 1C). No difference was found in the number of neurons between the acute and chronic phases (p = 0.0649). The same result was observed in the comparison between the controls (p = 0.2222). The last criterion for evaluating intestinal lesion progression was collagen deposition. As expected, no significant alteration in intestinal collagen deposition was observed in the acute phase; however, chronic infection induced a significant increase in collagen deposition when compared to the control group (p = 0.0001) and the acute phase group (p = 0.0017) (Fig 1D). No T. cruzi intestinal nests were found in either phase of the experimental infection in the HE intestinal sections.

Experimental T. cruzi infection induces intestinal IFNγ and BMP2 upregulation in the acute phase

In order to evaluate the immune response, the intestinal expression of cytokines was quantified at both experimental times. T. cruzi infection induced a significant increase in IFNγ production in both the acute phase (p = 0.0043) and the chronic phase (p = 0.0185) (Fig 2A). No statistical differences were found in the levels of intestinal TNF-α between infected and uninfected mice (Fig 2B). In addition, for both phases, no differences between the intestinal IL-10 levels of infected and uninfected mice were observed (Fig 2C), showing that infection was not regulated in this tissue. After confirming that the experimental model causes relevant histopathological and immunological changes, favoring intestinal inflammation, we evaluated whether BMP2 levels had also changed in the infected intestine. In the acute phase of infection, a significant increase in BMP2 production was observed compared to the control (p = 0.0303) (Fig 2D). In addition, the amount of BMP2 present in the intestine decreased in the chronic phase when compared to the acute phase (p = 0.0420), reaching the same level as that of the control basal production (Fig 2D).

[Figure omitted. See PDF.]

Fig 2. Intestinal immunological differences between the acute and chronic phases of T. cruzi infected C57Bl/6 mice.

Quantification of the intestinal levels of (A) IFNγ, (B) TNF-α, (C) IL-10, and (D) BMP2 in picograms/mg. Data are presented for C57Bl/6 mice that were either not infected or infected with 1000 blood trypomastigote forms of the T. cruzi Y strain in the acute and chronic experimental phases of the disease. Mann-Whitney test. * Significant statistical differences at p <0.05.

https://doi.org/10.1371/journal.pone.0246692.g002

BMP2 is related to immunopathological changes only in the acute phase of experimental Chagas disease

Since we observed, in the acute phase of the infection, significant BMP2, and IFNγ increases, we asked if IFNγ production could be correlated with the BMP2 increase. Interestingly, there was a strong, positive, and significant correlation between these two cytokines (Fig 3A) (p = 0.0039 and r = 0.8091, respectively). In the chronic phase, intestinal BMP2 returned to basal levels, abrogating the positive correlation (p = 0.1338 and r = 0.3789) (Fig 3B). For the next step, we asked whether these cytokines could be correlated with intestinal neuronal loss. There was a significant and strong and a moderate negative correlation between the number of neurons and the intestinal concentration of IFNγ (Fig 3C) and BMP2 (Fig 3D), respectively (p = 0.0162, r = -0.7182 and p = 0.0277, r = -0.6727) in the acute phase. No significant correlation was found between BMP2 and the number of intestinal neurons in the chronic phase (p = 0.6870, r = -0.1321) (Fig 3E).

[Figure omitted. See PDF.]

Fig 3. Correlations between intestinal IFNγ, BMP2, and myenteric neurons in the acute and chronic phases of T. cruzi-infected C57Bl/6 mice.

Correlations between the intestinal IFNγ and BMP2 levels at the (A) acute and (B) chronic phases. Correlations between the number of neurons and the levels of intestinal (C) IFNγ in the acute phase, BMP2 in (D) the acute phase and (E) the chronic phase. The data presented are from C57Bl/6 mice infected with 1000 blood trypomastigote forms of T. cruzi Y strain. Correlations were performed using the Spearman test. Significant statistical differences at p < 0.05.

https://doi.org/10.1371/journal.pone.0246692.g003

Discussion

This study aimed to investigate BMP2 intestinal production in C57Bl/6 mice infected with the Y strain of T. cruzi as well as to correlate this production with parameters related to the immunopathogenesis of the experimental infection. Our results demonstrate that infection induces the production of BMP2 differently in acute and chronic infections. A significant intestinal BMP2 increase was observed at 30 days of infection, and this was closely related to the intestinal IFNγ increment and neuronal loss. As this is the first report on intestinal BMP2 production in a protozoan disease, it is possible that there is a relationship between the imbalance we observed in the levels of this protein and the acute pathophysiology of intestinal CD.

It is already well established that strain Y parasitemia in experimental animals occurs quickly and in the first days after infection [20, 33], as observed in our study. The C57BL/6 mice is also well established in experiments related to an experimental CD, including in the study of intestinal changes [20, 34–37]. The intensity of the inflammatory infiltrate differs among infections caused by different strains and among different inocula of T. cruzi [20, 32, 38]. Independent of the strain used for murine infection, the acute phase is characterized by an intense inflammatory infiltrate when compared with the chronic phase [17, 31, 39], as was observed in our study. The inflammatory infiltrate was observed to be of greater intensity in the acute phase (moderate) than in the chronic phase (mild), which may be related to the fact that increased BMP2 levels were only observed at the beginning of the infection. In the stomachs of patients infected with Helicobacter pylori, it was observed that the inflammatory infiltrate induced by the infection produced BMP2, which was related to the increase of this protein in the organ [12]. In our study, the inflammatory infiltrate and BMP2 levels increased concomitantly. We believe that the inflammatory cells may influence the amount of BMP2 produced in the intestine during the acute phase. In vitro, BMP2 is able to induce chemotaxis, adhesion, and inhibit monocyte differentiation to the macrophage-M2 profile of human monocytes, which inhibits tissue repair and promotes the maintenance of the pro-inflammatory M1 profile, with an increase in pro-inflammatory molecules [40].

It was observed that BMP2 expression demonstrated a positive and significant correlation with IFNγ production in the intestine during the acute phase. Two mechanisms can be suggested from this result: 1) the increase in BMP2 was induced by the pro-inflammatory cytokines that increased in the acute phase and/or 2) BMP2 per se induced an increase in pro-inflammatory cytokines. Studies on bone regeneration have shown that BMP2 increases the production of pro-inflammatory cytokines in a dose-dependent manner [41–43]. In addition, stimulation of human endothelial cells (HMEC-1) with TNF-α resulted in an increase in the production of BMP2 [44]. The same authors also suggested a synergistic effect of these two cytokines (TNF-α and BMP2) in the establishment of the inflammatory process to induce an inflammatory phenotype in endothelial cells [44]. The ability of IFNγ and IL-1β to induce a BMP2 increase has also been demonstrated in the pancreatic cells of humans and murine models [45]. Although not evaluated in this study, the levels of pro-inflammatory cytokines, such as IL-12, IL-6, IL-2, and IL-17, have been reported to be elevated in the intestine during the acute experimental phase with the Y strain, in a manner that is dependent on the protozoan inoculum concentration [20]. In addition, it is suggested that the lack of balance between pro-inflammatory, regulatory, and anti-inflammatory cytokines results in the development and progression of CD [46–49]. The role of these cytokines is important both in the control of the protozoan [50–52] and in host tissue damage [34, 53]. Therefore, IFNγ and other pro-inflammatory cytokines could induce intestinal BMP2 upregulation, and vice versa. The interaction between IFNγ and BMP2 in maintaining the intestinal inflammatory profile during the acute phase of experimental T. cruzi infection, excludes the BMP2 participation in the chronic phase, in which there is a decrease in the inflammatory infiltrate, which results in decreased BMP2 production and no significant correlation with IFNγ in the intestine.

In experimental animals [54–56] and in humans [16, 21–23], T. cruzi infection decreases the number of nerve cells, and the acute phase has a leading role in this intensity [34, 57], as observed in our experimental model. The presence of inflammatory infiltrates together with pro-inflammatory cytokines, such as IFNγ, represents a way to contain the parasite during the initial events of T. cruzi infection [50]. In addition to attempting to control the infection, the production of IFNγ is related to neuronal decrease by inducing the production of nitric oxide via iNOS in an experimental model [34]. In our study, we found a strong negative correlation between the intestinal IFNγ levels and the number of neurons in the myenteric plexus, especially in the acute phase of experimental infection. While lymphocytes have already been demonstrated as a source of IFNγ [50, 51], natural killer cells and macrophages, which are at elevated levels in the chagasic megacolon [16], may also be responsible for the response to IFNγ (natural killer cells can produce IFNγ too) and produce NO, resulting in damage to the ENS. In fact, in an in vitro co-culture model with macrophages and neurons, phagocytes infected with T. cruzi and stimulated only with IFNγ induced neuronal death and neuritis by producing NO via iNOS [53]. In addition, the pathway associated with neuronal death in this model was attributed to necrosis of these cells [53]. Finally, when iNOS-/- macrophages and NO blockers were used, neural death was mitigated by decreasing NO production, corroborating the neurotoxic action of this molecule [53]. Neurodegeneration has also been demonstrated in vivo in C57BL/6 mice IL-12/IL-23 (IL-12p40KO) deficient mice [58]. In this model, Bombeiro et al. (2010) suggested that IFNγ, together with the glia protein S100β, induces NO overproduction by both the inflammatory infiltrate and resident glial cells in the spinal cord [58]. In addition to necrosis, apoptosis and autophagy are also induced by NO in several neurological pathological conditions [58]. Moreover, IFNγ by itself is also considered neurotoxic because it induces neurons to produce NO via nNOS, an enzyme responsible for the production of neuronal NO [59] and neuronal toxicity [60]. Thus, these data corroborate the negative correlation between the IFNγ level and number of neurons found in our study, suggesting that one of the neuronal death pathways is dependent on IFNγ production.

In addition to the correlation involving IFNγ, a moderate, negative, and significant correlation was observed between the BMP2 level and the number of myenteric plexus neuron cells but only during the acute phase of the experimental infection. In fact, the imbalance in the production of this protein has already been observed to be related to changes in intestinal functionality and neuronal loss in a rat model of diabetes and in Hirschsprung’s disease [10, 11]. Furthermore, previous studies have demonstrated that an increase in BMP2 in neurons of the hippocampus of rats exposed to arsenic induced neuronal apoptosis via SMADs [61]. In addition, a high concentration of BMP2 in vitro has been shown to increase the proportion of apoptotic cells in primary cortical neurons [62]. Thus, we speculate that the BMP2 increase represents a new pathway for neuronal death, along with IFNγ, in the intestinal form of experimental CD during the acute phase, a determining moment for the decrease of nerve cells.

Although there is a reduction in the inflammatory process in the chronic phase, tissue damage continues to progress, as observed in our model, through the increasing deposition of intestinal collagen after 90 days of infection. The mechanisms involved in the progression of CD are still debated. The parasitic load at the beginning of the infection, integration of kDNA into the host cells, (auto)immune response, and the persistence of the protozoans are factors that are collectively related to tissue damage, which over long time periods results in cell destruction, followed by fibrosis, and ultimately loss of tissue function in the most severe forms of CD [31, 63–66]. Although it is accepted that T. cruzi infection induces an inflammatory process associated with neuronal death, other components, such as the destruction of Cajal cells, smooth muscle cells [67], and enteric glial cells [16], are also related to the progression of megacolon and loss of motility and intestinal function.

BMP2 can also represent another component related to the intestinal fibrotic process that has not yet been evaluated in CD. In experimental models of chronic pancreatitis [68], renal fibrosis [69], and pulmonary fibrosis [70], BMP2 has been reported to have anti-fibrotic properties, mainly related to inhibition of TGF-β-related pathways. Based on this information, we speculate that, at the beginning of the infection, the increase in BMP2 is related to the inhibition of intestinal remodeling in our model. In the chronic phase, in which there is no BMP2, collagen deposition occurs.

From the results obtained in this study, some hypotheses can be developed regarding the role of BMP2 in experimental CD. This protein can act in several ways to participate in the progression of intestinal changes observed during T. cruzi infection. Briefly, we propose that, during the acute phase of infection, the increase in BMP2 is related to 1) the increase in inflammatory cells producing BMP2, 2) the maintenance of the intestinal proinflammatory profile, and 3) neuronal destruction. However, it is also plausible that, by inhibiting intestinal remodeling in the early stages of experimental infection, BMP2 plays a dual role. These findings may represent a new mechanism of interaction between the immune and nervous systems in the progression of Chagas disease.

Supporting information

S1 File.

https://doi.org/10.1371/journal.pone.0246692.s001

(XLSX)

Acknowledgments

We thank the Universidade Federal de Goiás and Universidade Federal do Triângulo Mineiro, especially the technicians of the General Pathology Discipline: Alberto, Edson, Liliane, and Vandair.

Citation: do Carmo Neto JR, Vinicius da Silva M, Braga YLL, Florencio da Costa AW, Fonseca SG, Nagib PRA, et al. (2021) Correlation between intestinal BMP2, IFNγ, and neural death in experimental infection with Trypanosoma cruzi. PLoS ONE 16(2): e0246692. https://doi.org/10.1371/journal.pone.0246692

References

1. Goldstein AM, Brewer KC, Doyle AM, Nagy N, Roberts DJ. BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system. Mech Dev. 2005;122(6):821–33. pmid:15905074

2. Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. Bone Morphogenetic Proteins: A critical review. Cell Signal. 2011 Apr;23(4):609–20. pmid:20959140

3. Chalazonitis A, D’Autréaux F, Pham TD, Kessler JA, Gershon MD. Bone morphogenetic proteins regulate enteric gliogenesis by modulating ErbB3 signaling. Dev Biol. 2011 Feb;350(1):64–79. pmid:21094638

4. Kashima R, Hata A. The role of TGF-β superfamily signaling in neurological disorders. Acta Biochim Biophys Sin (Shanghai). 2018;50(1):106–20. pmid:29190314

5. Ampuja M, Kallioniemi A. Transcription factors—Intricate players of the bone morphogenetic protein signaling pathway. Genes Chromosom Cancer. 2018;57(1):3–11. pmid:28857319

6. Chen D, Zhao M, Mundy GR. Bone Morphogenetic Proteins. Growth Factors. 2004 Dec;22(4):233–41. pmid:15621726

7. Muller PA, Koscsó B, Rajani GM, Stevanovic K, Berres ML, Hashimoto D, et al. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell. 2014;158(2):300–13. pmid:25036630

8. Chen K, Xie W, Luo B, Xiao W, Teitelbaum DH, Yang H, et al. Intestinal mucosal barrier is injured by BMP2/4 via activation of NF- B signals after ischemic reperfusion. Mediators Inflamm. 2014;2014. pmid:25132736

9. Locati M. Macrophages Have a Grip on the Gut. Immunity. 2014;41(1):11–3. pmid:25035949

10. Wu M, Chen W, Mi J, Chen D, Wang W, Gao H. Expression analysis of BMP2, BMP5, BMP10 in human colon tissues from Hirschsprung disease patients. Int J Clin Exp Pathol. 2014;7(2):529–36. pmid:24551273

11. Honoré SM, Zelarayan LC, Genta SB, Sánchez SS. Neuronal loss and abnormal BMP/Smad signaling in the myenteric plexus of diabetic rats. Auton Neurosci Basic Clin. 2011;164(1–2):51–61. pmid:21737358

12. Bleuming SA, Kodach LL, Garcia Leon MJ, Richel DJ, Peppelenbosch MP, Reitsma PH, et al. Altered bone morphogenetic protein signalling in the Helicobacter pylori-infected stomach. J Pathol. 2006;209(2):190–7. pmid:16550632

13. Adad SJ, Barbosa E Silva G, Jammal AA. The significantly reduced number of interstitial cells of Cajal in chagasic megacolon (CM) patients might contribute to the pathophysiology of CM. Virchows Arch. 2012;461(4):385–92. pmid:22895866

14. Oliveira EC1, Freitas MAR2, Brehmer A3 DSA. Immunological Challenges to the Development of Chagasic Mega Syndromes. Int J Cell Sci Mol Biol [Internet]. 2018;3(5).

15. da Silveira ABM, Adad SJ, Correa-Oliveira R, Furness JB, D’Avila Reis D. Morphometric study of eosinophils, mast cells, macrophages and fibrosis in the colon of chronic chagasic patients with and without megacolon. Parasitology. 2007;134(6):789–96. pmid:17288632

16. da Silveira ABM, Lemos EM, Adad SJ, Correa-Oliveira R, Furness JB, D’Avila Reis D. Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. Hum Pathol [Internet]. 2007;38(8):1256–64. pmid:17490721

17. Campos CF, Cangussú SD, Duz ALC, Cartelle CT, De Lourdes Noviello M, Veloso VM, et al. Enteric neuronal damage, intramuscular denervation and smooth muscle phenotype changes as mechanisms of Chagasic megacolon: Evidence from a long-term murine model of tripanosoma cruzi infection. PLoS One. 2016;11(4):1–18.

18. Molina HA, Kierszenbaum F. Interaction of human eosinophils or neutrophils with Trypanosoma cruzi in vitro causes bystander cardiac cell damage. Immunology. 1989;66(2):289–95. pmid:2647628

19. Kannen V, Sakita JY, Carneiro ZA, Bader M, Alenina N, Teixeira RR, et al. Mast Cells and Serotonin Synthesis Modulate Chagas Disease in the Colon: Clinical and Experimental Evidence. Dig Dis Sci. 2018;63(6):1473–84. pmid:29569002

20. Vazquez BP, Vazquez TP, Miguel CB, Rodrigues WF, Mendes MT, De Oliveira CJF, et al. Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load. Parasites and Vectors. 2015;8(1):206. pmid:25889515

21. Tafuri WL. Light and electron microscope studies of the autonomic nervous system in experimental and human American trypanosomiasis. Virchows Arch Abteilung A Pathol Anat. 1971;354(2):136–49. pmid:5000755

22. Adad SJ, Andrade DC, Lopes ER, Chapadeiro E. Pathological anatomy of chagasic megaesophagus. Rev Inst Med Trop Sao Paulo. 1991;33(6):443–50. pmid:1844974

23. Adad SJ, Cançado CG, Etchebehere RM, Teixeira VPA, Gomes UA, Chapadeiro E, et al. Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis. Virchows Arch. 2001;438(3):254–8. pmid:11315622

24. da SILVEIRA ABM, ARANTES RME, VAGO AR, LEMOS EM, ADAD SJ, CORREA-OLIVEIRA R, et al. Comparative study of the presence of Trypanosoma cruzi kDNA, inflammation and denervation in chagasic patients with and without megaesophagus. Parasitology. 2005;131(5):627–34. pmid:16255821

25. Maifrino LBM, Amaral SON, Watanabe I, Liberti EA, Souza RR De. Trypanosoma cruzi: Preliminary investigation of NADH-positive and somatostatin–immunoreactive neurons in the myenteric plexus of the mouse colon during the infection. 2005;111:224–9. pmid:16202412

26. Kramer K, Alexandre BM, Brehmer A. Quantitative evaluation of neurons in the mucosal plexus of adult human intestines. 2011;1–9.

27. Furness JB. The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol; 2012;9: 286–94. pmid:22392290

28. Freitas MAR, Segatto N, Pedro , Remolli F, Oliveira EC de, Jabari S, et al. Neurotrophin Expression in Chagasic Megacolon. 2017;1(3):1013

29. BRENER Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo. 1962;4:389–96. pmid:14015230

30. Araújo-Jorge TC de, Castro SL de. Doença de chagas: manual para experimentação animal. Doença de chagas: manual para experimentação animal. Editora FIOCRUZ; 2000.

31. Wesley M, Moraes A, Rosa A de C, Carvalho JL, Shiroma T, Vital T, et al. Correlation of parasite burden, kdna integration, autoreactive antibodies, and cytokine pattern in the pathophysiology of chagas disease. Front Microbiol. 2019;10(AUG):1856.

32. Reis Machado J, Silva MV, Borges DC, Da Silva CA, Ramirez LE, Dos Reis MA, et al. Immunopathological aspects of experimental Trypanosoma cruzi reinfections. Biomed Res Int. 2014;2014: 648715. pmid:25050370

33. Souza NDD, Belin BS, Massocatto CL, Araújo SMD, Sant’ana DMG, Araújo EJA, et al. Effect of acetylsalicylic acid on total myenteric neurons in mice experimentally infected with Trypanosoma cruzi. An Acad Bras Cienc. 2019;91(2):e20180389. pmid:31141012

34. Arantes RME, Marche HHF, Bahia MT, Cunha FQ, Rossi MA, Silva JS. Interferon-γ-Induced Nitric Oxide Causes Intrinsic Intestinal Denervation in Trypanosoma cruzi-Infected Mice. Am J Pathol. 2004;164(4):1361–8. pmid:15039223

35. De Souza AP, Sieberg R, Li H, Cahill HR, Zhao D, Araújo-Jorge TC, et al. The role of selenium in intestinal motility and morphology in a murine model of Typanosoma cruzi infection. Parasitol Res. 2010;106(6):1293–8. pmid:20195635

36. Andrade LO, Machado CRS, Chiari E, Pena SDJ, Macedo AM. Trypanosoma cruzi: Role of host genetic background in the differential tissue distribution of parasite clonal populations. Exp Parasitol. 2002;100(4):269–75. pmid:12128054

37. Pereira N de S, Queiroga TBD, da Silva DD, Nascimento MSL, Andrade CM de, Souto JT de, et al. NOD2 receptor is crucial for protecting against the digestive form of Chagas disease. PLoS Negl Trop Dis. 2020;14(9):e0008667. pmid:32986710

38. Espinoza B, Solorzano-Domínguez N, Vizcaino-Castillo A, Martínez I, Elias-López AL, Rodríguez-Martínez JA. Gastrointestinal infection with Mexican TcI Trypanosoma cruzi strains: Different degrees of colonization and diverse immune responses. Int J Biol Sci. 2011;7(9):1357–70. pmid:22110387

39. Mateus J, Guerrero P, Lasso P, Cuervo C, González JM, Puerta CJ, et al. An animal model of acute and chronic chagas disease with the reticulotropic Y strain of Trypanosoma cruzi that depicts the multifunctionality and dysfunctionality of T cells. Front Immunol. 2019;10(APR):918.

40. Pardali E, Makowski LM, Leffers M, Borgscheiper A, Waltenberger J. BMP-2 induces human mononuclear cell chemotaxis and adhesion and modulates monocyte-to-macrophage differentiation. J Cell Mol Med. 2018;22(11):5429–38. pmid:30102472

41. Zara JN, Siu RK, Zhang X, Shen J, Ngo R, Lee M, et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng—Part A. 2011;17(9–10):1389–99. pmid:21247344

42. Lee KB, Taghavi CE, Song KJ, Sintuu C, Yoo JH, Keorochana G, et al. Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model. Spine (Phila Pa 1976). 2011;36(3):E149–54.

43. Mitchell K, Shah JP, Dalgard CL, Tsytsikova L V., Tipton AC, Dmitriev AE, et al. Bone morphogenetic protein-2-mediated pain and inflammation in a rat model of posterolateral arthrodesis. BMC Neurosci. 2016;17(1):80. pmid:27905881

44. Sanders LN, Schoenhard JA, Saleh MA, Mukherjee A, Ryzhov S, McMaster WG, et al. BMP antagonist gremlin 2 limits inflammation after myocardial infarction. Circ Res. 2016;119(3):434–49. pmid:27283840

45. Ibarra Urizar A, Friberg J, Christensen DP, Lund Christensen G, Billestrup N. Inflammatory Cytokines Stimulate Bone Morphogenetic Protein-2 Expression and Release from Pancreatic Beta Cells. J Interf Cytokine Res. 2016;36(1):20–9. pmid:26308798

46. Da Silva MV, De Almeida VL, De Oliveira WD, Matos Cascudo NC, De Oliveira PG, Da Silva CA, et al. Upregulation of Cardiac IL-10 and Downregulation of IFN-γ in Balb/c IL-4 −/− in Acute Chagasic Myocarditis due to Colombian Strain of Trypanosoma cruzi. Mediators Inflamm. 2018;2018:3421897. pmid:30622430

47. D’Ávila DA, Guedes PMM, Castro AM, Gontijo ED, Chiari E, Galvão LMC. Immunological imbalance between IFN-γ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. Mem Inst Oswaldo Cruz. 2009;104(1):100–5. pmid:19274383

48. Cunha-Neto E, Chevillard C. Chagas disease cardiomyopathy: Immunopathology and genetics. Mediators Inflamm. 2014;2014:683230. pmid:25210230

49. Guedes PMM, Gutierrez FRS, Silva GK, Dellalibera-Joviliano R, Rodrigues GJ, Bendhack LM, et al. Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas’ disease. PLoS Negl Trop Dis. 2012;6(4):e1630. pmid:22545173

50. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β. Eur J Immunol. 1992;22(10):2501–6. pmid:1396957

51. Vespa GNR, Cunha FQ, Silva JS. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun. 1994;62(11):5177–82. pmid:7523307

52. Miyazaki Y, Hamano S, Wang S, Shimanoe Y, Iwakura Y, Yoshida H. IL-17 Is Necessary for Host Protection against Acute-Phase Trypanosoma cruzi Infection. J Immunol. 2010;185(2):1150–7. pmid:20562260

53. Megale de Almeida-Leite C, da Cunha Galvão LM, Afonso LCC, de Queiróz Cunha F, Arantes RME. Interferon-γ induced nitric oxide mediates in vitro neuronal damage by Trypanosoma cruzi-infected macrophages. Neurobiol Dis. 2007;25(1):170–8. pmid:17056264

54. Machado EMM, Camilo Júnior DJ, Pinheiro SW, Lopes ER, Fernandes AJ, Dias JCP, et al. Morphometry of Submucous and Myenteric Esophagic Plexus of Dogs Experimentally Reinfected with Trypanosoma cruzi. Mem Inst Oswaldo Cruz. 2001;96(4):545–8. pmid:11391429

55. Moreira NM, Sant’ana DMG, Araújo EJA, Toledo MJO, Gomes ML, de Araújo SM. Neuronal changes caused by Trypanosoma cruzi: An experimental model. An Acad Bras Cienc. 2011;83(2):545–55. pmid:21670878

56. Moreira NM, Santos FN, Jean M, Toledo O, Moraes SMF, Araujo EJA, et al. Moderate physical exercise reduces parasitaemia and protects colonic myenteric neurons in mice infected with Trypanosoma cruzi. Int J Exp Pathol. 2013;94(6):426–35. pmid:24205797

57. De Souza MM, Andrade SG, Barbosa AA, Santos RTM, Alves VAF, Andrade ZA. Trypanosoma cruzi Strains and Autonomic Nervous System Pathology in Experimental Chagas Disease. Mem Inst Oswaldo Cruz. 1996;91(2):217–24. pmid:8736094

58. Bombeiro AL D’Império Lima MR, Chadi G, Álvarez JM. Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-γ and s100β protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi. Neuroimmunomodulation. 2010;17(2):67–78. pmid:19923851

59. Mizuno T, Zhang G, Takeuchi H, Kawanokuchi J, Wang J, Sonobe Y, et al. Interferon‐γ directly induces neurotoxicity through a neuron specific, calcium‐permeable complex of IFN‐γ receptor and AMPA GluRl receptor. FASEB J. 2008;22(6):1797–806. pmid:18198214

60. Dawson TM, Dawson VL. Nitric Oxide Signaling in Neurodegeneration and Cell Death. Adv Pharmacol. 2018;82:57–83. pmid:29413528

61. Pandey R, Rai V, Mishra J, Mandrah K, Kumar Roy S, Bandyopadhyay S. From the Cover: Arsenic Induces Hippocampal Neuronal Apoptosis and Cognitive Impairments via an Up-Regulated BMP2/Smad-Dependent Reduced BDNF/TrkB Signaling in Rats. Toxicol Sci. 2017;159(1):137–58. pmid:28903487

62. Sun Q, Mao S, Li H, Zen K, Zhang CY, Li L. Role of miR-17 family in the negative feedback loop of bone morphogenetic protein signaling in neuron. PLoS One. 2013;8(12):e83067. pmid:24349434

63. Scharfstein J, Gomes J de AS, Correa-Oliveira R. Back to the future in Chagas disease: From animal models to patient cohort studies, progress in immunopathogenesis research. Mem Inst Oswaldo Cruz. 2009;104(SUPPL. 1):187–98. pmid:19753474

64. Jabari S, De Oliveira EC, Brehmer A, Da Silveira ABM. Chagasic megacolon: Enteric neurons and related structures. Histochem Cell Biol. 2014;142(3):235–44. pmid:25059649

65. De Bona E, Lidani KCF, Bavia L, Omidian Z, Gremski LH, Sandri TL, et al. Autoimmunity in chronic chagas disease: A road of multiple pathways to cardiomyopathy?. Front Immunol. 2018;9:1842 pmid:30127792

66. Bonney KM, Luthringer DJ, Kim SA, Garg NJ, Engman DM. Pathology and Pathogenesis of Chagas Heart Disease. Annu Rev Pathol. 2019;14:421–447 pmid:30355152

67. Jabari S, da Silveira ABM, de Oliveira EC, Quint K, Wirries A, Neuhuber W, et al. Interstitial cells of Cajal: Crucial for the development of megacolon in human Chagas’ disease? Color Dis. 2013;15(10):e592–8. pmid:23810202

68. Gao X, Cao Y, Yang W, Duan C, Aronson JF, Rastellini C, et al. BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation. Am J Physiol Gastrointest Liver Physiol. 2013;304(9):G804–13. pmid:23429583

69. Yang YL, Liu YS, Chuang LY, Guh JY, Lee TC, Liao TN, et al. Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type i transforming growth factor-β receptors. Endocrinology. 2009;150(2):727–40. pmid:18832104

70. Myllärniemi M, Lindholm P, Ryynänen MJ, Kliment CR, Salmenkivi K, Keski-Oja J, et al. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir Crit Care Med. 2008;177(3):321–9. pmid:17975199